All In Biotech

Free tool

FAERS Monitor: Subvenite

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 218879 or its brand name (Subvenite, Lamotrigine). Reports on generic versions are filed under their own applications.

Reports

72,862

Serious

58,992

81% of reports

Hospitalization

24,162

Death reported

8,331

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective6,370
  • seizure4,360
  • toxicity to various agents4,055
  • off label use3,588
  • drug interaction3,308
  • completed suicide3,096
  • fatigue3,078
  • dizziness3,048
  • nausea3,032
  • rash2,950
  • foetal exposure during pregnancy2,803
  • headache2,763
  • somnolence2,630
  • depression2,460
  • vomiting2,396

Reports by year received

View as table
YearReports
2004292
2005396
2006458
2007474
2008887
20091,569
20101,591
20111,999
20122,158
20132,064
20142,256
20153,089
20163,716
20174,244
20185,236
20195,717
20205,532
20215,352
20224,967
20235,236
20245,638
20255,668
20264,322

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,981,297 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal4,36011.311.039,531
completed suicideSignal3,09611.110.727,495
foetal exposure during pregnancySignal2,80310.39.922,734
toxicity to various agentsSignal4,0557.16.920,853
drug interactionSignal3,3086.15.913,994
somnolenceSignal2,6303.83.75,421
depressionSignal2,4603.13.03,595
rash2,9502.01.91,406
dizziness3,0481.81.71,036
vomiting2,3961.51.4370
drug ineffective6,3701.41.4763
headache2,7631.31.2166
off label use3,5881.21.1106
fatigue3,0781.11.156
nausea3,0321.11.132

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.